ZITHROMAX- azithromycin dihydrate tablet, film coated 
ZITHROMAX- azithromycin dihydrate powder, for suspension 
Pfizer Laboratories Div Pfizer Inc


Patient Information

ZITHROMAX® (Zith-roe-maks)

Oral Suspension

Read this Patient Information leaflet before you start taking ZITHROMAX and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.


ZITHROMAX is a macrolide antibiotic prescription medicine used in adults 18 years or older to treat certain infections caused by certain germs called bacteria. These bacterial infections include:

ZITHROMAX is also used in children to treat:

Azithromycin should not be taken by people who cannot tolerate oral medications because they are very ill or have certain other risk factors including:

ZITHROMAX is not for viral infections such as the common cold.

It is not known if ZITHROMAX is safe and effective for genital ulcers in women.

It is not known if ZITHROMAX is safe and effective for children with ear infections, sinus infections, and community-acquired pneumonia under 6 months of age.

It is not known if ZITHROMAX is safe and effective for infected throat or tonsils in children under 2 years of age.

Who should not take ZITHROMAX?

Do not take ZITHROMAX if you:

What should I tell my healthcare provider before taking ZITHROMAX?

Before you take ZITHROMAX, tell your healthcare provider if you:

Contact your healthcare provider immediately if you are giving ZITHROMAX to a young child (less than 6 weeks of age) and he or she vomits or becomes irritable when fed.

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

ZITHROMAX and other medicines may affect each other causing side effects. ZITHROMAX may affect the way other medicines work, and other medicines may affect how ZITHROMAX works.

Especially tell your healthcare provider if you take:

Know the medicines you take. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

How should I take ZITHROMAX?

What are the possible side effects of ZITHROMAX?

ZITHROMAX can cause serious side effects, including:

These are not all the possible side effects of ZITHROMAX. Tell your healthcare provider about any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store ZITHROMAX?

Keep ZITHROMAX and all medicines out of the reach of children.

General information about the safe and effective use of ZITHROMAX.

Medicines are sometimes prescribed for purposes other than those listed in the Patient Information leaflet. Do not use ZITHROMAX for a condition for which it was not prescribed.

Do not give ZITHROMAX to other people, even if they have the same symptoms you have.

It may harm them.

This Patient Information leaflet summarizes the most important information about ZITHROMAX. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about ZITHROMAX that is written for health professionals.

For more information, go to www.zithromax.com or call 1-800-438-1986.

What are the ingredients in ZITHROMAX Tablets and Oral Suspension?

ZITHROMAX Tablets and Oral Suspension

Active ingredient: azithromycin dehydrate


Inactive ingredients: dibasic calcium phosphate anhydrous, pregelatinized starch, sodium croscarmellose, magnesium stearate, sodium lauryl sulfate, hypromellose, lactose, titanium dioxide, triacetin, and D&C Red #30 aluminum lake.

ZITHROMAX Oral Suspension:

Inactive ingredients: sucrose; sodium phosphate, tribasic, anhydrous; hydroxypropyl cellulose; xanthan gum; FD&C Red #40; and spray dried artificial cherry, creme de vanilla, and banana flavors.

This Patient Information has been approved by the U.S. Food and Drug Administration.


Revised April 2019

Revised: 3/2019
Document Id: 5b2e15d4-567b-4bf7-a341-0fe0dc6f3d6c
Set id: db52b91e-79f7-4cc1-9564-f2eee8e31c45
Version: 30
Effective Time: 20190326
Pfizer Laboratories Div Pfizer Inc